259 related articles for article (PubMed ID: 25275557)
1. Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo.
Abdel-Mohsen M; Deng X; Danesh A; Liegler T; Jacobs ES; Rauch A; Ledergerber B; Norris PJ; Günthard HF; Wong JK; Pillai SK
PLoS One; 2014; 9(10):e109220. PubMed ID: 25275557
[TBL] [Abstract][Full Text] [Related]
2. Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.
Pillai SK; Abdel-Mohsen M; Guatelli J; Skasko M; Monto A; Fujimoto K; Yukl S; Greene WC; Kovari H; Rauch A; Fellay J; Battegay M; Hirschel B; Witteck A; Bernasconi E; Ledergerber B; Günthard HF; Wong JK;
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3035-40. PubMed ID: 22315404
[TBL] [Abstract][Full Text] [Related]
3. Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment.
Massanella M; Tural C; Papagno L; Garcia E; Jou A; Bofill M; Autran B; Clotet B; Blanco J
Antivir Ther; 2010; 15(3):333-42. PubMed ID: 20516553
[TBL] [Abstract][Full Text] [Related]
4. OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy.
Bruno R; Cariti G; Nasta P; Capetti A; Ravasio V; Galli M; Raise E; Palmieri G; Iannacone C; Puoti M
Liver Int; 2015 Jan; 35(1):120-9. PubMed ID: 25041136
[TBL] [Abstract][Full Text] [Related]
5. Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b.
Vispo E; Barreiro P; Rodriguez-Nóvoa S; Morello J; Labarga P; Martín-Carbonero L; Maida I; García-Gascó P; Soriano V
Antivir Ther; 2008; 13(4):511-7. PubMed ID: 18672529
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin.
Laguno M; Larrousse M; Murillas J; Blanco JL; León A; Milinkovic A; Loncá M; Martinez E; Sánchez-Tapias JM; de Lazzari E; Gatell JM; Costa J; Mallolas J
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):174-8. PubMed ID: 17106276
[TBL] [Abstract][Full Text] [Related]
7. Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women.
Nasta P; Maida I; Cattelan AM; Pontali E; Angeli E; Giralda M; Verucchi G; Caputo A; Iannacone C; Puoti M; Carosi G
J Womens Health (Larchmt); 2015 Feb; 24(2):159-64. PubMed ID: 25682817
[TBL] [Abstract][Full Text] [Related]
8. Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.
Neumann A; Polis M; Rozenberg L; Jackson J; Reitano K; McLaughlin M; Koratich C; Dewar R; Masur H; Haagmans B; Kottilil S
AIDS; 2007 Sep; 21(14):1855-65. PubMed ID: 17721093
[TBL] [Abstract][Full Text] [Related]
9. INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.
Abutidze A; Bolokadze N; Chkhartishvili N; Sharvadze L; Tsertsvadze T
Georgian Med News; 2016 Mar; (252):10-5. PubMed ID: 27119828
[TBL] [Abstract][Full Text] [Related]
10. The influence of treatment with pegylated interferon-alfa and ribavirin on neutrophil function and death in patients with HIV/HCV coinfection.
Jablonowska E; Wojcik K; Nocun M
Viral Immunol; 2012 Apr; 25(2):166-72. PubMed ID: 22324288
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8.
Tokumoto Y; Hiasa Y; Uesugi K; Watanabe T; Mashiba T; Abe M; Kumagi T; Ikeda Y; Matsuura B; Onji M
J Infect Dis; 2012 Apr; 205(7):1121-30. PubMed ID: 22357660
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C therapy with interferon-α and ribavirin reduces CD4 T-cell-associated HIV-1 DNA in HIV-1/hepatitis C virus-coinfected patients.
Sun H; Buzon MJ; Shaw A; Berg RK; Yu XG; Ferrando-Martinez S; Leal M; Ruiz-Mateos E; Lichterfeld M
J Infect Dis; 2014 May; 209(9):1315-20. PubMed ID: 24277743
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replication.
Chou WW; Huang CF; Yeh ML; Tsai YS; Hsieh MY; Huang CI; Huang JF; Tsai PC; Hsi E; Juo SH; Tsai WL; Chuang WL; Yu ML; Dai CY
J Mol Med (Berl); 2016 Mar; 94(3):311-20. PubMed ID: 26489607
[TBL] [Abstract][Full Text] [Related]
14. Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin.
Laufer N; Laguno M; Perez I; Cifuentes C; Murillas J; Vidal F; Bonet L; Veloso S; Gatell JM; Mallolas J
Antivir Ther; 2008; 13(7):953-7. PubMed ID: 19043930
[TBL] [Abstract][Full Text] [Related]
15. Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.
Bolcic F; Bull L; Martinez L; Reynoso R; Salomon H; Arduino R; Barnett B; Quarleri J
Intervirology; 2008; 51(4):261-4. PubMed ID: 18824873
[No Abstract] [Full Text] [Related]
16. Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).
Sherman KE; Andersen JW; Butt AA; Umbleja T; Alston B; Koziel MJ; Peters MG; Sulkowski M; Goodman ZD; Chung RT;
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):597-605. PubMed ID: 20921898
[TBL] [Abstract][Full Text] [Related]
17. Pegylated Interferon-α-Induced Natural Killer Cell Activation Is Associated With Human Immunodeficiency Virus-1 DNA Decline in Antiretroviral Therapy-Treated HIV-1/Hepatitis C Virus-Coinfected Patients.
Hua S; Vigano S; Tse S; Zhengyu O; Harrington S; Negron J; Garcia-Broncano P; Marchetti G; Genebat M; Leal M; Resino S; Ruiz-Mateos E; Lichterfeld M; Yu XG
Clin Infect Dis; 2018 Jun; 66(12):1910-1917. PubMed ID: 29272392
[TBL] [Abstract][Full Text] [Related]
18. Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.
Tural C; Solà R; Alvarez NP; Moltó J; Sánchez M; Zamora AM; Ornelas A; Laguno M; González J; von Wichmann MÁ; Téllez MJ; Paredes R; Clotet B;
Antivir Ther; 2011; 16(6):833-41. PubMed ID: 21900715
[TBL] [Abstract][Full Text] [Related]
19. Effect of ribavirin and interferon beta on miRNA profile in the hepatitis C virus subgenomic replicon-bearing Huh7 cells.
Gong BD; Xie Q; Xiang XG; Wang L; Zhao GD; An FM; Wang H; Lin LY; Yu H; Bao SS
Int J Mol Med; 2010 Jun; 25(6):853-9. PubMed ID: 20428788
[TBL] [Abstract][Full Text] [Related]
20. Effects of alpha interferon treatment on intrinsic anti-HIV-1 immunity in vivo.
Abdel-Mohsen M; Deng X; Liegler T; Guatelli JC; Salama MS; Ghanem Hel-D; Rauch A; Ledergerber B; Deeks SG; Günthard HF; Wong JK; Pillai SK
J Virol; 2014 Jan; 88(1):763-7. PubMed ID: 24155399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
